Climate Change Data

Jubilant Pharmova Limited

Climate Impact & Sustainability Data (2007-04 to 2008-03, 2022-23)

Reporting Period: 2007-04 to 2008-03

Environmental Metrics

Total Carbon Emissions:117754 tCO2e/year (direct) + 60251 tCO2e/year (indirect)
Water Consumption:485053 m3/year (groundwater) + 124543 m3/year (surface water) + 325457 m3/year (municipal)

ESG Focus Areas

  • Environment
  • Social
  • Economic

Environmental Achievements

  • Reduced water consumption by more than 8% at the Gajraula plant.
  • Achieved more than 50% recovery of acetic acid from the waste stream.
  • Implemented several energy conservation schemes.

Social Achievements

  • Continued focus on basic healthcare and primary education in communities near manufacturing units.
  • Launched HIV/AIDS awareness campaign covering employees, truckers, and migrant laborers.
  • Implemented safety training programs with Chilworth Safety & Risk Management.

Governance Achievements

  • Integrated sustainability into its activities, recognized by IFC and Standard & Poor's.

Climate Goals & Targets

Long-term Goals:
  • Increase ammonia recovery in pyridine production.
  • Reduce raffinate quantity in pyridine production.
Medium-term Goals:
  • Implement school health program 'Nirog Bachpan' in seven schools at Gajraula.
  • Strengthen sustainability efforts with supply chain partners.
Short-term Goals:
  • Start mobile dispensary services at Nira and Nanjangud.
  • Replicate Muskaan project in six more schools at Gajraula.

Environmental Challenges

  • One fatal accident at the Nira unit.
  • Technical issues hindering solvent recovery (achieved 30% instead of 60% target).
  • Foreign currency exposures due to global operations and exports.
Mitigation Strategies
  • Intensified safety measures to prevent future accidents.
  • Addressing technical barriers to achieve solvent recovery targets.
  • Utilizing forward contracts or derivatives to mitigate foreign currency risks.

Supply Chain Management

Responsible Procurement
  • Annual vendor meet; new vendor evaluation form focusing on EHS and CSR.

Climate-Related Risks & Opportunities

Physical Risks
  • Impact on molasses supply due to climate change.
Opportunities
  • Clean Development Mechanism (CDM) projects.

Reporting Standards

Frameworks Used: GRI G3

Certifications: ISO 14001 (four units)

Third-party Assurance: Ernst & Young Private Limited

UN Sustainable Development Goals

  • Goal 1: No Poverty
  • Goal 2: Zero Hunger
  • Goal 3: Good Health and Well-being
  • Goal 4: Quality Education

Community development activities focusing on healthcare, primary education, and income generation.

Sustainable Products & Innovation

  • Solvent-free polyurethane adhesives; products using biocides and APEO-free surfactants.

Awards & Recognition

  • Golden Peacock Global Award for CSR
  • Golden Peacock Global Award for Corporate Governance
  • Featured in Standard & Poor's ESG Index
  • Jubilant Sustainability Report short-listed for Reader’s Choice award
  • Featured in IFC document
  • A+ rating from GRI
  • Invited to International meet in Moscow

Reporting Period: 2022-23

Environmental Metrics

Total Carbon Emissions:753,972.74 tCO2e (Scope 1 & 2)
Scope 1 Emissions:8492 tCO2
Scope 2 Emissions:54703 tCO2
Scope 3 Emissions:662,296 Metric tonnes of CO2 equivalent
Total Energy Consumption:753,972.74 (A+B+C)
Water Consumption:602461.77 kilolitres
Waste Generated:13343.0 metric tonnes

ESG Focus Areas

  • Climate Change
  • Water
  • Waste Management
  • Human Rights
  • Community
  • Occupational Health and Safety
  • Training and development
  • Employee attrition
  • Direct Economic Value Generated
  • Compliance
  • Customer Satisfaction
  • Responsible Supply Chain

Environmental Achievements

  • Reduced absolute greenhouse gas (GHG) emissions year after year
  • 22% reduction in specific energy consumption compared to FY 2019 baselines
  • 20.9% decrease in specific water consumption compared to FY 2019 baselines
  • 55.1% reduction in specific greenhouse gas (GHG) emissions compared to FY 2019 baselines
  • 38% reduction in absolute GHG emissions since FY 2019

Social Achievements

  • Maintained a gender diversity ratio of 25.2%
  • Implemented Driver Safety training program (Driver Insights) in US Radiopharmacy business

Governance Achievements

  • 94% percentile in the S&P Global ESG Indices CSA 2022 (DJSI)
  • GOLD Sustainability rating in EcoVadis (top 5% of global pharmaceutical companies)
  • ‘B’ score band from CDP for ‘Climate Change’ and ‘Water Security’

Climate Goals & Targets

Environmental Challenges

  • Climate Change
  • Water
  • Waste Management
  • Human Rights
  • Community
  • Occupational Health and Safety
  • Training and development
  • Employee attrition
  • Direct Economic Value Generated
  • Compliance
  • Customer Satisfaction
  • Responsible Supply Chain
Mitigation Strategies
  • Board of Directors constituted a Risk Management Committee (RMC) to formulate detailed Risk Management Policy and oversee risk management process and systems.
  • Sanchetna portal to record hazards and implement Corrective Action Preventive Action (CAPA)
  • HumanTech software to assess ergonomic risks

Supply Chain Management

Supplier Audits: 39% (API business under Indian Operation)

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI standards, Carbon Disclosure Project (CDP), Dow Jones Sustainability Index (DJSI), UNGC principles, Sustainable Development Goals (SDGs)

Certifications: OHSAS 18001 / ISO 45001, ISO 14001, ISO 9001, ISO 27001

Third-party Assurance: Ernst & Young Associates & LLP